Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker
- PMID: 32968402
- PMCID: PMC7501019
- DOI: 10.12669/pjms.36.6.2678
Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker
Abstract
Objective: To determine the association of serum osteoprotegerin (OPG) with the severity of chronic liver disease in female patients.
Methods: This case-control study was conducted in Madina Teaching Hospital from 2019-2020.An institutional review board of University Medical and Dental College, The University of Faisalabad gave the approval to conduct the study. Only female patients of age group 40 to 60 years having CLD were included in this study. Total 80 participants were enrolled after fulfilling the inclusion and exclusion criteria. Serum OPG levels were measured by enzyme linked immunosorbant assay (ELISA) supplied by ELAB Sciences, USA. The severity of disease was assessed by Child-Pugh classification.
Results: OPG levels were significantly different between the three Child-Pugh classes. OPG levels were significantly high in class C indicating increased level of this cytokine in CLD as compared to class A (p = <0.05). There was a positive association of OPG with splenomegaly (OR = 2.10, p = <0.001), hepatomegaly (OR = 4.41, (p = <0.05), skin pigmentation (OR = 2.06, p = <0.05), malena (OR = 1.87, p = <0.05) and prolonged bleeding (OR = 1.86, p = <0.05).
Conclusion: The levels of serum Osteoprotegerin is increased in severe form of chronic liver disease (Class C) of Child-Pughs classification as compared to mild (Class A) and moderate (Class B) forms of Child-Pughs classification.
Keywords: Chronic liver disease; Hepatomegaly; Osteoprotegerin; liver cirrhosis.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Conflicts of interest: None.
Similar articles
-
Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.Cureus. 2020 Dec 26;12(12):e12294. doi: 10.7759/cureus.12294. Cureus. 2020. PMID: 33520498 Free PMC article.
-
Concentrations of fetuin-A, osteoprotegerin and α-Klotho in patients with alcoholic liver cirrhosis.Exp Ther Med. 2016 Nov;12(5):3464-3470. doi: 10.3892/etm.2016.3754. Epub 2016 Sep 27. Exp Ther Med. 2016. PMID: 27882180 Free PMC article.
-
Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis.Folia Med Cracov. 2014;54(2):17-26. Folia Med Cracov. 2014. PMID: 25648306
-
Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease.Cureus. 2019 Aug 21;11(8):e5454. doi: 10.7759/cureus.5454. Cureus. 2019. PMID: 31641555 Free PMC article.
-
The RANKL/OPG system and bone mineral density in patients with chronic liver disease.J Hepatol. 2005 Dec;43(6):973-83. doi: 10.1016/j.jhep.2005.05.034. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143421
References
-
- Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38:2–6. doi:10.1111/liv.13682. - PubMed
-
- Peters S, Clézardin P, Márquez-Rodas I, Niepel D, Gedye C. The RANK–RANKL axis:an opportunity for drug repurposing in cancer? Clin Transl Oncol. 2019:1–5. doi:10.1007/s12094-018-02023-5. - PubMed
LinkOut - more resources
Full Text Sources